Autoreactive processes in children in the initial period of multisystem inflammatory syndrome associated with SARS-CoV-2 and after rehabilitation
- Authors: Obukhova O.O.1, Ryabichenko T.I.1, Skosyreva G.A.1, Izyumov A.O.2, Timofeeva E.P.2, Shvayuk A.P.1, Stankevich N.N.1, Voevoda M.I.1
-
Affiliations:
- Federal Research Center for Fundamental and Translational Medicine
- Novosibirsk State Medical University
- Issue: Vol 14, No 5 (2023)
- Pages: 41-49
- Section: Original studies
- URL: https://journal-vniispk.ru/pediatr/article/view/252877
- DOI: https://doi.org/10.17816/PED626015
- ID: 252877
Cite item
Abstract
BACKGROUND: The problem of the pathogenesis of the multisystem inflammatory syndrome (MIS-C), associated with SARS-CoV-2, remains relevant, but is still far from being resolved. In this regard.
AIM: The aim our research was to study and evaluate the levels of autoantibodies to native and denatured DNA in the blood serum of children who underwent MIS-C, associated with SARS-CoV-2, in comparison with the initial period of the pathological process.
MATERIALS AND METHODS: 101 children aged 2 to 17 years old were examined, 77 of them was with a confirmed diagnosis of MIS-C associated with SARS-CoV-2. We have formed 3 groups: group 1 — children with MIS-C upon admission to the hospital; group 2 — children who underwent MIS-C after a course of rehabilitation; group 3 — comparison group. All children underwent determination of the concentrations of IgG-autoantibodies to native and denatured DNA in blood serum, which was performed by EIA ELISA using commercial test systems of Vector-Best LLC (Russia) according to the manufacturer’s instructions. Statistical processing of the obtained results was carried out using the Statistica v. 10.0 application package. Statistical processing used the Newman–Keuls multiple comparison test.
RESULTS: It was noted that both in the initial period of MIS-C and after rehabilitation, an increased content of autoantibodies to nDNA and dDNA was determined compared to the control group. At the same time, there was a significant excess of the levels of indicators in the post-rehabilitation period compared with the initial period of MIS-C. During a clinical examination of children who underwent MIS-C, most of them noted the appearance of pain in the joints. The results obtained indicate the persistence of inflammatory reactions with the development of an autoreactive component. This requires both the search for risk markers for the development of MIS-C and further monitoring of children who have undergone MIS-C to prevent autoimmune complications, including arthritis, damage to the vascular endothelium with the possible formation of thrombotic complications.
CONCLUSIONS: In the acute period of MIS-C and after rehabilitation, increased levels of the average content of autoantibodies to nDNA and dDNA were noted compared to the control. Individual values of autoantibodies to nDNA and dDNA exceeded normative levels of the indicator were found in a significantly larger number of children in the post-rehabilitation period after MIS-C, and this excess was more pronounced compared to the acute period of the process. When assessing the clinical condition of children after MIS-C, most of them showed pain in the joints during exercise, abdominal and neurological disorders, and decreased tolerance to physical activity, which indicates persistent inflammatory reactions.
Full Text
##article.viewOnOriginalSite##About the authors
Olga O. Obukhova
Federal Research Center for Fundamental and Translational Medicine
Author for correspondence.
Email: trio188@yandex.ru
ORCID iD: 0000-0002-9834-1799
SPIN-code: 1638-8225
MD, PhD, Dr. Sci. (Medicine), Chef Researcher, Laboratory of immunology
Russian Federation, NovosibirskTatyana I. Ryabichenko
Federal Research Center for Fundamental and Translational Medicine
Email: 2925871@mail.ru
ORCID iD: 0000-0002-0990-0078
SPIN-code: 1919-6218
MD, PhD, Dr. Sci. (Medicine), Leading Research Associate, Laboratory of Immunology
Russian Federation, NovosibirskGalina A. Skosyreva
Federal Research Center for Fundamental and Translational Medicine
Email: skosyreva43@mail.ru
ORCID iD: 0000-0001-5477-3445
MD, PhD, Dr. Sci. (Medicine), Senior Research Associate, Laboratory of Immunology
Russian Federation, NovosibirskAlexander O. Izyumov
Novosibirsk State Medical University
Email: izumovao@yandex.ru
ORCID iD: 0000-0002-1223-1995
SPIN-code: 4790-0154
MD, PhD, Associate Professor, Department of Pediatric Dentistry
Russian Federation, NovosibirskElena P. Timofeeva
Novosibirsk State Medical University
Email: timofeevae.p@mail.ru
ORCID iD: 0000-0003-0657-5705
SPIN-code: 5311-9252
MD, PhD, Associate Professor, Department of propaedeutics of childhood diseases
Russian Federation, NovosibirskAlya P. Shvayuk
Federal Research Center for Fundamental and Translational Medicine
Email: alya.shvayuk@bk.ru
ORCID iD: 0000-0002-8247-7085
PhD, Senior Research Associate, Immunology Laboratory
Russian Federation, NovosibirskNadezhda N. Stankevich
Federal Research Center for Fundamental and Translational Medicine
Email: nadya.stankevich.2023@mail.ru
ORCID iD: 0009-0008-4110-7142
Postgraduate Student, Immunology Laboratory
Russian Federation, NovosibirskMikhail I. Voevoda
Federal Research Center for Fundamental and Translational Medicine
Email: mvoevoda@ya.ru
ORCID iD: 0000-0001-9425-413X
SPIN-code: 6133-1780
MD, PhD, Dr. Sci. (Medicine), Director
Russian Federation, NovosibirskReferences
- Lobzin YuV, Vilnits AA, Kostik MM, et al. Pediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues. Journal Infectology. 2021;13(1):13–20. doi: 10.22625/2072-6732-2021-13-1-13-20
- Kantemirova MG, Novikova YuYu, Ovsyannikov DYu, et al. Children’s multisystem inflammatory syndrome, associated with a new coronavirus infection (COVID-19): Relevant Information and clinical observation. Pediatric pharmacology. 2020;17(3):219–229. doi: 10.15690/pf.v17i3.2126
- Khaliullina SV, Anokhin VA, Sadykova DI, et al. Post-COVID syndrome in children. Russian Bulletin of Perinatology and Pediatrics. 2021;66(5):188–193. doi: 10.21508/1027-4065-2021-66-5-188-193
- Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–436. doi: 10.1161/CIRCULATIONAHA.120.048360
- Bouhaddou M, Memon D, Meyer B, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182(3):685–712.e19. doi: 10.1016/j.cell.2020.06.034
- Cappello F. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Cell Stress Chaperones. 2020;25(3):381–382. doi: 10.1007/s12192-020-01112-1
- Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968–81.e7. doi: 10.1016/j.cell.2020.09.016
- Correction to Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2019;140(5): e181–184. doi: 10.1161/CIR.0000000000000703
- Cuomo AM, Zucker HA, Dreslin S. Health advisory: pediatric multi-system inflammatory syndrome potentially associated with Renavs disease (COVID-19) children. New York State of Opportunity. Department of Health. 2020;226(1):45–54.
- Dietz SM, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease: a state of the art review. Eur J Pediatr. 2017;176(8):995–1009. doi: 10.1007/s00431-017-2937-5
- Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc Health. 2020;4(10):790–794. doi: 10.1016/S2352-4642(20)30257-1
- Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10(6):537–540. doi: 10.1542/hpeds.2020-0123
- Kotlarz A, Tukaj S, Krzewski K, et al. Human Hsp40 proteins, DNAJA1 and DNAJA2, as potential targets of the immune response triggered by bacterial DnaJ in rheumatoid arthritis. Cell Stress Chaperones. 2013;18(5):653–659. doi: 10.1007/s12192-013-0407-1
- Lin Z, Shi J-L, Chen M, et al. CCL2: An important cytokine innormal and pathological pregnancies: A review. Front Immunol. 2023;13:1053457. doi: 10.3389/fimmu.2022.1053457
- Riphagen S, Gomez X, Gonzales-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608. DOI: 10.106/S0140-6736(20)31094-1
- St John AL, Rathore APS. Early insights into immune responses during COVID-19. J Immunol. 2020;205(3):555–564. doi: 10.4049/jimmunol.2000526
- Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CоV-2. JAMA. 2020;324(3): e2010369. doi: 10.1001/jama.2020.10369
- www.who.int [Internet]. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19 [cited 2023 May 15]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
- Wu L, O’Kane AM, Peng H, et al. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochem Pharmacol. 2020;178:114114. doi: 10.1016/j.bcp.2020.114114
Supplementary files
